Making treatment decisions is a tough choice for oncologists: a therapy might save or significantly extend one patient’s life but not deliver the desired outcome for another patient.
This year’s ASCO showed us that while COVID-19 might be front and centre of everyone’s minds, the desire to see real change in cancer treatment hasn’t diminished. In this issue
